ArticleCancer science2020

MET amplification results in heterogeneous responses to osimertinib in EGFR-mutant lung cancer treated with erlotinib.

Akihiro Nishiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.